Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia.

Zabotti A, McGonagle DG, Giovannini I, Errichetti E, Zuliani F, Zanetti A, Tinazzi I, De Lucia O, Batticciotto A, Idolazzi L, Sakellariou G, Zandonella Callegher S, Sacco S, Quartuccio L, Iagnocco A, De Vita S.

RMD Open. 2019 Oct 23;5(2):e001067. doi: 10.1136/rmdopen-2019-001067. eCollection 2019.

2.

Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression.

Cuthbert RJ, Watad A, Fragkakis EM, Dunsmuir R, Loughenbury P, Khan A, Millner PA, Davison A, Marzo-Ortega H, Newton D, Bridgewood C, McGonagle DG.

Ann Rheum Dis. 2019 Nov;78(11):1559-1565. doi: 10.1136/annrheumdis-2019-215210. Epub 2019 Sep 17.

3.

Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al.

Buch MH, Melville A, McGonagle DG.

Ann Rheum Dis. 2019 Jul 13. pii: annrheumdis-2019-215881. doi: 10.1136/annrheumdis-2019-215881. [Epub ahead of print] No abstract available.

4.

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies.

McGonagle DG, McInnes IB, Kirkham BW, Sherlock J, Moots R.

Ann Rheum Dis. 2019 Sep;78(9):1167-1178. doi: 10.1136/annrheumdis-2019-215356. Epub 2019 Jul 5. Review. Erratum in: Ann Rheum Dis. 2020 Jan;79(1):e12.

5.

Identification of myeloid cells in the human enthesis as the main source of local IL-23 production.

Bridgewood C, Watad A, Russell T, Palmer TM, Marzo-Ortega H, Khan A, Millner PA, Dunsmuir R, Rao A, Loughenbury P, Wittmann M, Cuthbert RJ, McGonagle DG.

Ann Rheum Dis. 2019 Jul;78(7):929-933. doi: 10.1136/annrheumdis-2018-214944. Epub 2019 Apr 24.

6.

Imaging of nuclear magnetic resonance spin-lattice relaxation activation energy in cartilage.

Foster RJ, Damion RA, Ries ME, Smye SW, McGonagle DG, Binks DA, Radjenovic A.

R Soc Open Sci. 2018 Jul 11;5(7):180221. doi: 10.1098/rsos.180221. eCollection 2018 Jul.

7.

MRI of psoriatic nail disease pre- and post-TNF inhibitor therapy shows persistent subclinical inflammation after 6 months despite good clinical response.

Ash Z, Tan AL, Hodgson RJ, Grainger A, Marzo-Ortega H, McGonagle DG.

RMD Open. 2018 Feb 2;4(1):e000599. doi: 10.1136/rmdopen-2017-000599. eCollection 2018. No abstract available.

8.

The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia.

Marchesoni A, De Marco G, Merashli M, McKenna F, Tinazzi I, Marzo-Ortega H, McGonagle DG.

Rheumatology (Oxford). 2018 Jan 1;57(1):32-40. doi: 10.1093/rheumatology/kex079. Review.

9.

An educational leaflet improves response to invitation for screening for arthritis in patients with psoriasis in primary care, but only in practices in the most deprived areas.

Coates LC, Savage L, Waxman R, McGonagle DG, Moverley AR, Helliwell PS.

Clin Rheumatol. 2017 Mar;36(3):719-723. doi: 10.1007/s10067-016-3503-7. Epub 2016 Dec 15.

10.

Response to: 'A relationship between extracapsular involvement and response to steroid treatment in polymyalgia rheumatica: too soon to conclude?' by Yang et al.

Mackie SL, McGonagle DG.

Ann Rheum Dis. 2016 Apr;75(4):e17. doi: 10.1136/annrheumdis-2015-208962. Epub 2016 Jan 27. No abstract available.

PMID:
26819098
11.

Prolonged remission of marginal zone lymphoma in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor agents.

Donaldson SL, Owen RG, McGonagle DG.

J Rheumatol. 2014 Dec;41(12):2496-7. doi: 10.3899/jrheum.140725. No abstract available.

PMID:
25452189
12.

Response to: 'Which B-cell subset should we target in lupus?' by Ferraccioli and Houssiau.

Arumugakani G, Vital EM, Md Yusof MY, McGonagle DG, Emery P.

Ann Rheum Dis. 2014 Apr;73(4):e20. doi: 10.1136/annrheumdis-2013-205096. Epub 2014 Jan 15. No abstract available.

PMID:
24431390
13.

Magnetic resonance imaging assessment of axial psoriatic arthritis: extent of disease relates to HLA-B27.

Castillo-Gallego C, Aydin SZ, Emery P, McGonagle DG, Marzo-Ortega H.

Arthritis Rheum. 2013 Sep;65(9):2274-8. doi: 10.1002/art.38050.

14.

Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma.

Abignano G, Aydin SZ, Castillo-Gallego C, Liakouli V, Woods D, Meekings A, Wakefield RJ, McGonagle DG, Emery P, Del Galdo F.

Ann Rheum Dis. 2013 Nov;72(11):1845-51. doi: 10.1136/annrheumdis-2012-202682. Epub 2013 Feb 20.

PMID:
23426041
15.

Enthesitis in psoriatic disease.

McGonagle DG, Helliwell P, Veale D.

Dermatology. 2012;225(2):100-9. doi: 10.1159/000341536. Epub 2012 Oct 27. Review.

PMID:
23108016
16.

The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development.

Aydin SZ, Ash ZR, Tinazzi I, Castillo-Gallego C, Kwok C, Wilson C, Goodfield M, Gisondi P, Tan AL, Marzo-Ortega H, Emery P, Wakefield RJ, McGonagle DG.

Ann Rheum Dis. 2013 Jun;72(6):992-5. doi: 10.1136/annrheumdis-2012-201617. Epub 2012 Aug 3.

PMID:
22863575
17.

Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails.

Ash ZR, Tinazzi I, Gallego CC, Kwok C, Wilson C, Goodfield M, Gisondi P, Tan AL, Marzo-Ortega H, Emery P, Wakefield RJ, McGonagle DG, Aydin SZ.

Ann Rheum Dis. 2012 Apr;71(4):553-6. doi: 10.1136/annrheumdis-2011-200478. Epub 2011 Dec 9.

PMID:
22156725
18.

Acetylcholine receptor antibodies in patients with genetic myopathies: clinical and biological significance.

Lane RJ, Roncaroli F, Charles P, McGonagle DG, Orrell RW.

Neuromuscul Disord. 2012 Feb;22(2):122-8. doi: 10.1016/j.nmd.2011.06.751. Epub 2011 Aug 26.

PMID:
21872471
19.

Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review.

Coates LC, Anderson RR, Fitzgerald O, Gottlieb AB, Kelly SG, Lubrano E, McGonagle DG, Olivieri I, Ritchlin CT, Tan AL, De Vlam K, Helliwell PS.

J Rheumatol. 2008 Jul;35(7):1438-42. Review.

PMID:
18609741
20.

Uveitis and tumour necrosis factor blockade in ankylosing spondylitis.

Coates LC, McGonagle DG, Bennett AN, Emery P, Marzo-Ortega H.

Ann Rheum Dis. 2008 May;67(5):729-30. doi: 10.1136/ard.2007.077370. No abstract available.

PMID:
18408116
21.

MRI of enthesitis of the appendicular skeleton in spondyloarthritis.

Eshed I, Bollow M, McGonagle DG, Tan AL, Althoff CE, Asbach P, Hermann KG.

Ann Rheum Dis. 2007 Dec;66(12):1553-9. Epub 2007 May 25. Review.

Supplemental Content

Loading ...
Support Center